FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileArtrya Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
AYA.AX
Artrya Limited Stock AnalysisComprehensive stock analysis for Artrya Limited (AYA.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAYA.AX
AYA.AX
Artrya Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
AYA.AX
  1. Home
  2. Stocks
  3. Artrya Limited

Artrya Limited

🇦🇺AYA.AX•ASX

Artrya Limited

🇦🇺AYA.AX•ASX

Your view on AYA.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Artrya Limited

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
John Konstantopoulos
Headquarters
1257 Hay Street, West Perth, WA, AU
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
John Konstantopoulos
Headquarters
1257 Hay Street, West Perth, WA, AU
Description

Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application.

Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Artrya Limited. Starting points for Artrya Limited: EPS -AUD 0.15, beta 0.63 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Artrya Limited. Artrya Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Artrya Limited. Trailing twelve-month EPS for Artrya Limited stands at -AUD 0.15. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimate−AUD 0.08−AUD 0.08−AUD 0.14−AUD 0.11
Lowest estimate−AUD 0.08−AUD 0.08−AUD 0.16−AUD 0.11
Highest estimate−AUD 0.08−AUD 0.08−AUD 0.12−AUD 0.09
Number of analysts1155
A year ago——−AUD 0.171—
Growth vs a year ago————

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 14000.00AUD 14000.00AUD 2.74MAUD 16.68M
Lowest estimateAUD 14000.00AUD 14000.00AUD 1.20MAUD 12.50M
Highest estimateAUD 14000.00AUD 14000.00AUD 6.02MAUD 19.39M
Number of analysts1145
A year ago——AUD 28000.00—
Growth vs a year ago——+9685.7%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Artrya Limited. Artrya Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold AYA.AX19 companies · 8 funds
Compare AYA.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
CGS.AXCogstate LimitedHealthcareMedical - Healthcare Information Services—
EIQ.AXEcho IQ LimitedBasic MaterialsOther Precious Metals—
ENL.AXEnlitic, Inc.HealthcareMedical - Healthcare Information Services—
IME.AXImExHS LimitedHealthcareMedical - Diagnostics & Research—
M7T.AXMach7 Technologies LimitedHealthcareMedical - Healthcare Information Services—
PME.AXPro Medicus LimitedHealthcareMedical - Healthcare Information Services—
RHT.AXResonance Health LimitedHealthcareMedical - Healthcare Information Services—
More Medical - Healthcare Information Services companies
TickerTypeCompanySectorExchangeMkt cap
TSTTFTripSitter Clinic Ltd.HealthcareOTC$145,814
TXG10x Genomics, Inc.HealthcareNASDAQ$6.9B
UDOC.CNUnidoc Health Corp.HealthcareCNQ$12.5M
UDOCFUnidoc Health Corp.HealthcareOTC$7.6M
UMCNUMC, Inc.HealthcareOTC$13.2M
UPHLUpHealth, Inc.HealthcareOTC$5,679
USPSUltimate Sports, Inc.HealthcareOTC$679,298
VASOVaso CorporationHealthcareOTC$31.7M
VFX.AXVisionflex Fpo [vfx]HealthcareASX—
VHI.TOVitalhub Corp.HealthcareTSX$421.8M
VHIBFVitalhub Corp.HealthcareOTC$359.8M
VHL.AXVitasora Health LimitedHealthcareASX—
ETFs holding Artrya Limited
TickerFundFund assets% of the fund
VXUSVanguard Total International Stock ETF$163.2B in assets0.00%
VEAVanguard FTSE Developed Markets ETF$231.6B in assets0.00%
VSSVanguard FTSE All-World ex-US Small-Cap ETF$11.6B in assets0.01%
SCHCSchwab International Small-Cap Equity ETF$5.4B in assets0.01%
VPLVanguard FTSE Pacific ETF$9.0B in assets0.00%
VTVanguard Total World Stock ETF$81.8B in assets0.00%
VIU.TOVanguard FTSE Developed All Cap ex North America Index ETF$11.4B in assets0.00%
VEQT.TOVanguard All-Equity ETF Portfolio$17.6B in assets0.00%

Largest holders first, then the funds most concentrated in AYA.AX.

Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Artrya Limited.

AYA.AX AnalysisFair
Past
1
Growth
2
Health
5
Profit
1
Value
1